Oral Health Related Quality of Life and Peri-implant Condition in Single Implant Overdenture
1 other identifier
interventional
78
1 country
1
Brief Summary
Comparing the quality of life and periimplant condition around a single implant retained mandibular overdenture in two groups one will have a ball attachment and the other is having a (CM-LOC) one.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable quality-of-life
Started Jan 2016
Typical duration for not_applicable quality-of-life
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 29, 2016
CompletedFirst Posted
Study publicly available on registry
August 10, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2018
CompletedSeptember 4, 2019
September 1, 2019
1.8 years
July 29, 2016
September 1, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
change in oral health related quality of life using (oral health impact profile edentulous) questionnaire (OHIP-EDENT)
likert scale from 0-4
from baseline up to 5 years
Secondary Outcomes (3)
change in modified gingival index
from baseline up to 5 years
change in plaque index
from baseline up to 5 years
modified bleeding index
from baseline up to 5 years
Study Arms (2)
CM LOC attachment
EXPERIMENTALCM LOC attachment other names: resin matrix attachment
ball attachment
ACTIVE COMPARATORball attachment other names metallic ball attachment
Interventions
Eligibility Criteria
You may qualify if:
- No contraindications for implantation.
- Each patient has to perform both a random blood sugar and Glycosylated Hemoglobin analysis. Patients with a Glycosylated hemoglobin test HbA1c up to 8% and a normal blood sugar level (79 to 110) or controlled diabetic patients (90-130 fasting according to American Association of Diabetes) will be included.
- Sufficient bone width (≥ 6 mm) in the anterior region to place an implant. It could be either normally present or achieved by bone plateauing. This will be confirmed by cone beam computed tomographic (CBCT) scans.
- Residual bone height ranging from 11-20 mm with the lowest vertical height in the midline of the mandible not less than 13 mm This will be confirmed by the CBCT.
- Patients seeking to install a single symphyseal implant and for whom new dentures will be constructed.
- Patients, who are dissatisfied with the retention and stability of their technically satisfactory dentures.
- Patients, who already have existing maxillary and mandibular complete dentures, and after examination of the mandibular dentures, it is found that there are technical problems with regard to denture design and/or occlusion; then new maxillary and mandibular dentures will be fabricated
- All patients should have adapted to their dentures for at least six weeks before being included in the trial.
- Patients providing written informed consents to participate in the trial and this will be done before the scheduled date for implant installation.
You may not qualify if:
- Patients with a systemic or local contra-indication for implant placement.
- Satisfied patients with the retention of their mandibular denture as well as unsatisfied patients with their maxillary denture.
- Patient with a mandibular denture height less than 6 mm between the base of the denture and the incisal edge of the central incisors (as measured by a caliper) or with 12 mm crown height space as measured by a ruler from the incisal edge till the crest of the ridge. This will be done from a putty index of the diagnostic set up.
- Incompliant and not cooperative patients.
- Patients smoking more than 10 cigarettes per day.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Removable Prosthodontic Department, Faculty of Oral and Dental Medicine - Cairo University
Cairo, +02, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
marwa AA mohammed, A lecturer
non affliated
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assisstant Lecturer
Study Record Dates
First Submitted
July 29, 2016
First Posted
August 10, 2016
Study Start
January 1, 2016
Primary Completion
October 1, 2017
Study Completion
April 1, 2018
Last Updated
September 4, 2019
Record last verified: 2019-09